| Press Releases | |
| August 21, 2006 | Verus Pharmaceuticals Announces Agreement with UCB for Commercialization of Twinject® in Europe |
| August 21, 2006 | Oscient Pharmaceuticals Completes Acquisition of Cardiovascular Therapy ANTARA(R) 130mg (fenofibrate) Capsules |
| August 10, 2006 | Oscient Pharmaceuticals and Abbott Canada Enter into Commercialization Agreement for FACTIVE Tablets |
| June 26, 2006 | Tercica Provides Increlex Launch and Safety Updates |
| June 5, 2006 | Tercica's Increlex Pricing Provides a Significant Competitive Advantage |
| May 25, 2006 | Critical Therapeutics' ZYFLO(R) Receives Distinct Classification under Medicare Prescription Drug Benefit |
| April 25, 2006 | QIAGEN Eliminates Key Bottleneck in Epigenetic Research |
| April 5, 2006 | HemoSense Expands INRatio Production Capacity Through Packaging Agreement with J-PAC |
| March 15, 2006 | Barrier Therapeutics Acquires the Canadian Distribution Rights for Denavir(R) |
| February 16, 2006 | Helsinn and Biovitrum enter a license agreement for Nordic marketing of Aloxi®, a drug that prevents nausea and vomiting in cancer patients |
| February 8, 2006 | Oscient Pharmaceuticals Acquires Expanded Worldwide Rights to Lead Clinical Candidate Ramoplanin |
| February 7, 2006 | Oscient Pharmaceuticals and Pfizer Enter Agreement for FACTIVE Tablets in Mexico |
| January 19, 2006 | CoTherix Announces Fourth Quarter Ventavis Sales and 2006 Revenue Guidance |
| January 12, 2006 | HemoSense Signs Agreement with ZyCare to Distribute INRatio and Utilize Web-Based Warfarin Patient Management System |
| January 3, 2006 | Tercica Launches Increlex in the U.S.; Only Drug Approved for the Long-Term Treatment of Growth Failure Caused by Severe Primary IGFD |
| December 13, 2005 | CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients |
| November 10, 2005 | Acorda Therapeutics® Partners with Cardinal Health to Expand Sales Force for ZANAFLEX CAPSULES™ |
| November 3, 2005 | Barrier Therapeutics Announces the Launch of VANIQA(R) in Canada |
| October 20, 2005 | HemoSense Signs Co-Marketing Agreement with Standing Stone to Offer Connectivity Solution for INRatio |
| October 11, 2005 | Critical Therapeutics Announces Commercial Launch of ZYFLO(R); Studies Showed ZYFLO Reduced the Need for Rescue Medications and Improved Asthma Symptoms |
| September 22, 2005 | Barrier Therapeutics to Retain Worldwide Rights to Hyphanox(TM) |
| September 22, 2005 | Verus Pharmaceuticals Announces Canadian Launch of Twinject for Anaphylaxis |
| August 30, 2005 | FDA Grants Expanded Label for Ventavis |
| August 16, 2005 | Verus Pharmaceuticals Announces U.S. Launch of Twinject for Anaphylaxis |
| July 28, 2005 | St. Jude Medical Announces Exclusive European Co-Promotion Alliance with HemoSense, Inc. to Assist Mechanical Heart Valve Patients with Anticoagulation Therapy Management |
| July 27, 2005 | Verus Pharmaceuticals Announces Agreement with Paladin Labs for
Commercialization of Twinject in Canada |
| July 6, 2005 | Verus Pharmaceuticals Announces Acquisition of Twinject for Anaphylaxis |
| June 22, 2005 | Barrier Therapeutics Acquires Canadian Distribution Rights for VANIQA(R) |
| May 2, 2005 | Barrier Therapeutics Announces Launch of U.S. Sales Organization |
| May 2, 2005 | Safety Profile of Macugen® (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMD) Maintained for Two Years |
| April 13, 2005 | Auxilium Pharmaceuticals and Oscient Pharmaceuticals Establish Co-Promotion Partnership for Testim 1% Testosterone Gel |
| April 6, 2005 | Oscient Pharmaceuticals and LG Life Sciences Amend FACTIVE License Agreement; Modifications include adjustments to royalty rate structure |
| April 5, 2005 | CHF Solutions Launches Aquadex(TM) Flexflow(TM) Fluid Removal System |
| April 4, 2005 | Acorda Therapeutics Launches ZANAFLEX CAPSULES for the Management of Spasticity in People with MS and Spinal Cord Injury |
| March 24, 2005 | HemoSense Signs Distribution Agreements with FDI Medical, STAT Technologies, and Whitmire Medical |
| March 22, 2005 | CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension |
| March 18, 2005 | Oscient Pharmaceuticals Completes Nationwide FACTIVE Sales Force Expansion; 250 territory managers and 25 district managers drive commercialization of FACTIVE |
| March 17, 2005 | Intercell AG and Biological E. Ltd Enter into a Strategic Alliance for the Development, Manufacture and Sales of its Japanese Encephalitis Vaccine |
| March 9, 2005 | Restore Medical Enters International Markets with Pillar® Procedure for Obstructive Sleep Apnea |
| February 16, 2005 | NEOSIL Acquires Topical Products from OsteoScreen |
| February 9, 2005 | Rhodia Pharma Solutions and Critical Therapeutics Sign Long-Term Supply Agreement for Zileuton |
| February 7, 2005 | Eyetech Pharmaceuticals, Inc. Announces Reimbursement Terms for Macugen® |
| February 7, 2005 | Barrier Therapeutics Acquires U.S. and Canadian Rights to SOLAGE(R) Topical Solution |
| January 20, 2005 | Eyetech Announces Launch Date for Macugen® (pegaptanib sodium injection) |